Seven Ingredients for Launching and Commercializing a Biopharma’s First Drug in Europe

For decades, the life sciences industry has been renowned as one of the most profitable and innovative industries in the world. However, despite tireless research and development efforts, many diseases are still lacking treatment options or are in need of more effective and/or safer treatment alternatives. Given these unmet needs and attractive business opportunities, many established companies as well as emerging biopharma startups have geared up to develop new drugs and treatment approaches.